Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Beta Bionics Inc.

    NASDAQ: BBNX · Real-Time Price · USD
    19.53
    0.44 (2.30%)
    At close: Jun 16, 2025, 3:59 PM
    20.39
    4.40%
    After-hours: Jun 16, 2025, 07:30 PM EDT

    Beta Bionics Statistics

    Share Statistics

    Beta Bionics has 43.36M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 43.36M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 26

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 4.13M, so 9.53% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.13M

    Short % of Shares Out

    n/a
    		 9.53%

    Short % of Float

    n/a
    		 10.77%

    Short Ratio (days to cover)

    n/a
    		 7.92

    Valuation Ratios

    The PE ratio is -2.75 and the forward PE ratio is -9.4. Beta Bionics's PEG ratio is -0.79.

    PE Ratio

    n/a
    		 -2.75

    Forward PE

    n/a
    		 -9.4

    PS Ratio

    n/a
    		 2.31

    Forward PS

    n/a
    		 2.7

    PB Ratio

    n/a
    		 1.98

    P/FCF Ratio

    n/a
    		 -2.91

    PEG Ratio

    n/a
    		 -0.79
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Beta Bionics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.29, with a Debt / Equity ratio of 0.1.

    Current Ratio

    n/a
    		 6.29

    Quick Ratio

    n/a
    		 5.66

    Debt / Equity

    n/a
    		 0.1

    Debt / EBITDA

    n/a
    		 -0.16

    Debt / FCF

    n/a
    		 -0.14

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $185,011.36

    Profits Per Employee

    n/a
    		 $-155,556.82

    Employee Count

    n/a
    		 352

    Asset Turnover

    n/a
    		 0.44

    Inventory Turnover

    n/a
    		 2.19

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 8.32, so Beta Bionics's price volatility has been higher than the market average.

    Beta

    n/a
    		 8.32

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 13.98

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 66.56

    Average Volume (20 Days)

    n/a
    		 562,517

    Income Statement

    In the last 12 months, Beta Bionics had revenue of 65.12M and earned -54.76M in profits. Earnings per share was -8.6.

    Revenue

    n/a
    		 65.12M

    Gross Profit

    n/a
    		 35.89M

    Operating Income

    n/a
    		 -45.25M

    Net Income

    n/a
    		 -54.76M

    EBITDA

    n/a
    		 -44.1M

    EBIT

    n/a
    		 -45.25M

    Earnings Per Share (EPS)

    n/a
    		 -8.6
    Full Income Statement

    Balance Sheet

    The company has 30.43M in cash and 7.25M in debt, giving a net cash position of 23.18M.

    Cash & Cash Equivalents

    n/a
    		 30.43M

    Total Debt

    n/a
    		 7.25M

    Net Cash

    n/a
    		 23.18M

    Retained Earnings

    n/a
    		 -296.74M

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -48.27M and capital expenditures -3.4M, giving a free cash flow of -51.67M.

    Operating Cash Flow

    n/a
    		 -48.27M

    Capital Expenditures

    n/a
    		 -3.4M

    Free Cash Flow

    n/a
    		 -51.67M

    FCF Per Share

    n/a
    		 -8.12
    Full Cash Flow Statement

    Margins

    Gross margin is 55.11%, with operating and profit margins of -69.48% and -84.08%.

    Gross Margin

    n/a
    		 55.11%

    Operating Margin

    n/a
    		 -69.48%

    Pretax Margin

    n/a
    		 -84.08%

    Profit Margin

    n/a
    		 -84.08%

    EBITDA Margin

    n/a
    		 -67.72%

    EBIT Margin

    n/a
    		 -69.48%

    FCF Margin

    n/a
    		 -79.34%

    Dividends & Yields

    BBNX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BBNX is $26, which is 33.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $26

    Price Target Difference

    n/a
    		 33.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist